From pharmacokinetics to therapeutics

References

• Abernethy, D.R., Barbey, J.T., Franc, J., Brown, K.S., Feirrera, I., Ford, N., Salazar, D.E. (2001). Loratadine and terfenadine interaction with nefazodone: both antihistamines are associated with QTc prolongation. Clin Pharmacol Ther 69:96–103.
   PubMed Web of Science ®Google Scholar
• Affrime, M., Banfield, C., Gupta, S., Cohen, A., Boutros, T., Thonoor, M., Cayen, M. (2002). Effect of race and sex on single- and multiple-dose pharmacokinetics of desloratadine. Clin Pharmacokinet 41(Suppl 1):21–28.
   PubMedGoogle Scholar
• Ariens, E.J., Simonis, A.M. (1964). The mode of action of biologically active compounds. In: Ariens, E.J., (Ed.), Molecular Pharmacology (pp 105–118 ). London/New York: Academic Press.
   Google Scholar
• Auclair, B., Wainer, I.W., Fried, K., Koch, P., Jerussi, T.P., Ducharme, M.P. (2000). A population analysis of nebulized (R)-albuterol in dogs using a novel mixed gut-lung absorption PK-PD model. Pharm Res 17:1228–1235.
   PubMed Web of Science ®Google Scholar
• Bachert, C., Bousquet, J., Canonica, G.W., Durham, S.R., Klimek, L., Mullol, J., et al. (2004). Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol 114:838–844.
   PubMed Web of Science ®Google Scholar
• Baltes, E., Coupez, R., Giezek, H., Voss, G., Meyerhoff, C., Strolin Benedetti, M. (2001). Absorption and disposition of levocetirizine, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers. Fundam Clin Pharmacol 15:269–277.
   PubMed Web of Science ®Google Scholar
• Beal, S.L., Sheiner, L.B., Boeckmann, A.J. (2009). NONMEM Users Guides, (1989–2006), Ellicott City, Maryland, USA: Icon Development Solutions.
   Google Scholar
• Canonica, G.W., Bousquet, J., Van, H.G., Bachert, C., Durham, S.R., Klimek, L., et al. (2006). Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. Respir Med 100:1706–1715.
   PubMed Web of Science ®Google Scholar
• Chakraborty, A., Krzyzanski, W., Jusko, W.J. (1999). Mathematical modeling of circadian cortisol concentrations using indirect response models: comparison of several methods. J Pharmacokinet Biopharm 27:23–43.
   PubMedGoogle Scholar
• Church, M.K., Griffiths, T.J., Jeffery, S., Ravell, L.C., Cowburn, A.S., Sampson, A.P., et al. (2002). Are cysteinyl leukotrienes involved in allergic responses in human skin? Clin Exp Allergy 32:1013–1019.
   PubMed Web of Science ®Google Scholar
• Ciprandi, G., Cirillo, I., Vizzaccaro, A., Civardi, E., Barberi, S., Allen, M., et al. (2005). Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study. Int Immunopharmacol 5:1800–1808.
   PubMed Web of Science ®Google Scholar
• Crane, J., von Mutius, E., Custovic, A. (2006). Epidemiology of allergic disease. In: Holgate, S.T., Church, M.K., Lichtenstein, L.M. (Eds.), Allergy (pp 234–246 ). London: Mosby.
   Google Scholar
• Daley-Yates, P.T., Richards, D.H. (2004). Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model. Clin Ther 26:1905–1919.
   PubMed Web of Science ®Google Scholar
• Day, J.H., Briscoe, M.P., Ratz, J.D. (2008). Efficacy of levocetirizine compared with montelukast in subjects with ragweed-induced seasonal allergic rhinitis in the environmental exposure unit. Allergy Asthma Proc 29:304–312.
   PubMed Web of Science ®Google Scholar
• Day, J.H., Ellis, A.K., Rafeiro, E., Ratz, J.D., Briscoe, M.P. (2006). Experimental models for the evaluation of treatment of allergic rhinitis. Ann Allergy Asthma Immunol 96:263–277.
   PubMed Web of Science ®Google Scholar
• Dayneka, N.L., Garg, V., Jusko, W.J. (1993). Comparison of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm 21:457–478.
   PubMedGoogle Scholar
• Denham, K.J., Boutsiouki, P., Clough, G.F., Church, M.K. (2003). Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin. Inflamm Res 52:424–427.
   PubMed Web of Science ®Google Scholar
• Desager, J.P., Horsmans, Y. (1995). Pharmacokinetic-pharmacodynamic relationships of H1-antihistamines. Clin Pharmacokinet 28:419–432.
   PubMed Web of Science ®Google Scholar
• Deschamps, C., Dubruc, C., Mentre, F., Rosenzweig, P. (2000). Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model. Clin Pharmacol Ther 68:647–657.
   PubMed Web of Science ®Google Scholar
• Dresser, G.K., Bailey, D.G., Leake, B.F., Schwarz, U.I., Dawson, P.A., Freeman, D.J., et al. (2002). Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 71:11–20.
   PubMed Web of Science ®Google Scholar
• Fetterly, G.J., Owen, J.S., Stuyckens, K., Passarell, J.A., Zannikos, P., Soto-Matos, A., et al. (2008). Semimechanistic pharmacokinetic/pharmacodynamic model for hepatoprotective effect of dexamethasone on transient transaminitis after trabectedin (ET-743) treatment. Cancer Chemother Pharmacol 62:135–147.
   PubMed Web of Science ®Google Scholar
• Friberg, L.E., Henningsson, A., Maas, H., Nguyen, L., Karlsson, M.O. (2002). Model of chemotherapy-induced myelosuppression with parameter consistency across drugs. J Clin Oncol 20:4713–4721.
   PubMed Web of Science ®Google Scholar
• Frossard, N., Strolin Benedetti, M., Purohit, A., Pauli, G. (2008). Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine. Br J Clin Pharmacol 65:172–179.
   PubMed Web of Science ®Google Scholar
• Garcia-Gea, C., Martinez-Colomer, J., Antonijoan, R.M., Valiente, R., Barbanoj, M.J. (2008). Comparison of peripheral and central effects of single and repeated oral dose administrations of bilastine, a new H1 antihistamine: a dose-range study in healthy volunteers with hydroxyzine and placebo as control treatments. J Clin Psychopharmacol 28:675–685.
   PubMed Web of Science ®Google Scholar
• Gillard, M., Chatelain, P. (2006). Changes in PH differently affect the binding properties of histamine H1 receptor antagonists. Eur J Pharmacol 530:205–214.
   PubMed Web of Science ®Google Scholar
• Gillard, M., Strolin Benedetti, M., Chatelain, P., Baltes, E. (2005). Histamine H1 receptor occupancy and pharmacodynamics of second-generation H1-antihistamines. Inflamm Res 54:367–369.
   PubMed Web of Science ®Google Scholar
• Gillard, M., Van Der Perren, C., Moguilevsky, N., Massingham, R., Chatelain, P. (2002). Binding characteristics of cetirizine and levocetirizine to human H1-histamine receptors: contribution of Lys(191) and Thr(194). Mol Pharmacol 61:391–399.
   PubMed Web of Science ®Google Scholar
• Gupta, S.K., Sathyan, G., Lindemulder, E.A., Ho, P.L., Sheiner, L.B., Aarons, L. (1999). Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships. Clin Pharmacol Ther 65:672–684.
   PubMed Web of Science ®Google Scholar
• Guyton, A.C. (1991). Blood pressure control—special role of the kidneys and body fluids. Science 252:1813–1816.
   PubMed Web of Science ®Google Scholar
• Hawrylowicz, C., MacGlashan, D.W., Saito, H., Simon, H-U., Wardlaw, A.J. (2006). Effector cells of allergy. In: Holgate, S.T., Church, M.K., Lichtenstein, L.M. (Eds.), Allergy (pp 351–373 ). London: Mosby.
   Google Scholar
• Heykants, J.J.P., Snoeck, E., Awouters, F., Van Peer, A. (1992). Antihistamines. In: Van Boxtel, C.J., Holford, N.H.G., Danhof, M. (Eds.), The In Vivo Study of Drug Action (pp 337–356 ). Amsterdam, The Netherlands: Elsevier.
   Google Scholar
• Holgate, S.T... (2006). The genetic basis of allergic disease. In: Holgate, S.T., Church, M.K., Lichtenstein, L.M. (Eds.), Allergy (pp 205–221 ). London: Mosby.
   Google Scholar
• Holgate, S.T. (2008). Pathogenesis of asthma. Clin Exp Allergy 38:872–897.
   PubMed Web of Science ®Google Scholar
• Houston, M.C., Hodge, R. (1988). Beta-adrenergic blocker withdrawal syndromes in hypertension and other cardiovascular diseases. Am Heart J 116:515–523.
   PubMed Web of Science ®Google Scholar
• Hutmacher, M.M., Krishnaswami, S., Kowalski, K.G. (2008). Exposure-response modeling using latent variables for the efficacy of a JAK3 inhibitor administered to rheumatoid arthritis patients. J Pharmacokinet Pharmacodyn 35:139–157.
   PubMed Web of Science ®Google Scholar
• Hyo, S., Fujieda, S., Kawada, R., Kitazawa, S., Takenaka, H. (2005). The efficacy of short-term administration of 3 antihistamines vs. placebo under natural exposure to Japanese cedar pollen. Ann Allergy Asthma Immunol 94:457–464.
   PubMed Web of Science ®Google Scholar
• Jonker, D.M., Kenna, C.H., Leishman, D., Wallis, R., Milligan, P.A., Jonnson, E.N. (2005). A pharmacokinetic - pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene currently inhibition data. Clin. Pharmacol. Ther. 77:572–582.
   PubMed Web of Science ®Google Scholar
• Kamal, M.A., Moston, A., Morlock, R., Feltner, D., Oullet, D. (2005). Comparison of continous and ordered categoncal psychemetric scales in measuring the time course of lorazepam-induced samnolence. Clin. Pharmacol. Ther. 77:p66.
   Google Scholar
• Karppinen, A., Brummer-Korvenkontio, H., Petman, L., Kautiainen, H., Herve, J.P., Reunala, T. (2006). Levocetirizine for treatment of immediate and delayed mosquito bite reactions. Acta Derm Venereol 86:329–331.
   PubMed Web of Science ®Google Scholar
• Kenakin, T. (2004). Principles: receptor theory in pharmacology. Trends Pharmacol Sci 25:186–192.
   PubMed Web of Science ®Google Scholar
• Kenakin, T., Jenkinson, S., Watson, C. (2006). Determining the potency and molecular mechanism of action of insurmountable antagonists. J Pharmacol Exp Ther 319:710–723.
   PubMed Web of Science ®Google Scholar
• Korsgren, M., Andersson, M., Larsson, L., den-Raboisson, M., Greiff, L. (2006). Onset of action of a topical antihistamine as assessed by histamine challenge-induced plasma exudation responses. Ann Allergy Asthma Immunol 96:345–348.
   PubMed Web of Science ®Google Scholar
• Krishnaswami, S., Hochhaus, G., Derendorf, H. (2000). An interactive algorithm for the assessment of cumulative cortisol suppression during inhaled corticosteroid therapy. AAPS PharmSci 2:E22.
   PubMedGoogle Scholar
• Larbig, M., Burtin, B., Martin, L., Stamm, H., Luettig, B., Hohlfeld, J.M., et al. (2006). Facial thermography is a sensitive tool to determine antihistaminic activity: comparison of levocetirizine and fexofenadine. Br J Clin Pharmacol 62:158–164.
   PubMed Web of Science ®Google Scholar
• Lima, J.J., Krukemyer, J.J., Boudoulas, H. (1989). Drug- or hormone-induced adaptation: model of adrenergic hypersensitivity. J Pharmacokinet Biopharm 17:347–364.
   PubMedGoogle Scholar
• Liu, X., Chen, C., Smith, B.J. (2008). Progress in brain penetration evaluation in drug discovery and development. J Pharmacol Exp Ther 325:349–356.
   PubMed Web of Science ®Google Scholar
• Mackie, A.E., Bye, A. (2000). The relationship between systemic exposure to fluticasone propionate and cortisol reduction in healthy male volunteers. Clin Pharmacokinet 39(Suppl 1):47–54.
   PubMedGoogle Scholar
• Mollmann, H., Wagner, M., Meibohm, B., Hochhaus, G., Barth, J., Stockmann, R., et al. (1998). Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration. Eur J Clin Pharmacol 53:459–467.
   PubMed Web of Science ®Google Scholar
• Monroe, E.W., Daly, A.F., Shalhoub, R.F. (1997). Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines. J Allergy Clin Immunol 99:S798–S806.
   PubMed Web of Science ®Google Scholar
• Piotrovsky, V. (2005). Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation. AAPS J 7:E609–E624.
   PubMed Web of Science ®Google Scholar
• Pipkorn, P., Costantini, C., Reynolds, C., Wall, M., Drake, M., Sanico, A., et al. (2008). The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation. Ann Allergy Asthma Immunol 101:82–89.
   PubMed Web of Science ®Google Scholar
• Popov, T.A., Dumitrascu, D., Bachvarova, A., Bocsan, C., Dimitrov, V., Church, M.K. (2006). A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo. Inflamm Res 55:241–244.
   PubMed Web of Science ®Google Scholar
• Prochnau, J.J., Busse, W.W., Holgate, S.T... (2006). Cellular and mediator mechanisms of allergic inflammation. In: Holgate, S.T., Church, M.K., Lichtenstein, L.M. (Eds.), Allergy (pp 389–405 ). London: Mosby.
   Google Scholar
• Purohit, A., Duvernelle, C., Melac, M., Pauli, G., Frossard, N. (2001). Twenty-four hours of activity of cetirizine and fexofenadine in the skin. Ann Allergy Asthma Immunol 86:387–392.
   PubMed Web of Science ®Google Scholar
• Purohit, A., Melac, M., Pauli, G., Frossard, N. (2003). Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin. Br J Clin Pharmacol 56:388–394.
   PubMed Web of Science ®Google Scholar
• Richardson, G.S., Roehrs, T.A., Rosenthal, L., Koshorek, G., Roth, T. (2002). Tolerance to daytime sedative effects of H1 antihistamines. J Clin Psychopharmacol 22:511–515.
   PubMed Web of Science ®Google Scholar
• Rohatagi, S., Appajosyula, S., Derendorf, H., Szefler, S., Nave, R., Zech, K., et al. (2004). Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective. J Clin Pharmacol 44:37–47.
   PubMed Web of Science ®Google Scholar
• Rohatagi, S., Bye, A., Mackie, A.E., Derendorf, H. (1996). Mathematical modeling of cortisol circadian rhythm and cortisol suppression. Eur J Pharm Sci 4:41–50.
   Google Scholar
• Salter, M., Biggadike, K., Matthews, J.L., West, M.R., Haase, M.V., Farrow, S.N., et al. (2007). Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease. Am J Physiol Lung Cell Mol Physiol 293:L660–L667.
   PubMed Web of Science ®Google Scholar
• Segre, G. (1968). Kinetics of interaction between drugs and biological systems. Farmaco [Sci ] 23:907–918.
   PubMedGoogle Scholar
• Sheiner, L.B., Stanski, D.R., Vozeh, S., Miller, R.D., Ham, J. (1979). Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to D-tubocurarine. Clin Pharmacol Ther 25:358–371.
   PubMed Web of Science ®Google Scholar
• Sibley, D.R., Lefkowitz, R.J. (1985). Molecular mechanisms of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase system as a model. Nature 317:124–129.
   PubMed Web of Science ®Google Scholar
• Simeoni, M., Van Der Graaf, PH., Milligan, P., Verotta, D., De Nicolao, G., Rocchetti, M., et al. (2005). Counting events: population approaches using NONMEM. PAGE 14:Abstract 789.
   Google Scholar
• Simons, K.J., Simons, F.E., Whomsley, R., Gillard, M., Strolin Benedetti, M. (2008). Hydroxyzine and its active metabolite cetirizine: H1-receptor occupancy in healthy elderly adults. Allergy 63: Abstract 1495.
   Web of Science ®Google Scholar
• Simons, K.J., Strolin Benedetti, M., Simons, F.E., Gillard, M., Baltes, E. (2007). Relevance of H1-receptor occupancy to H1-antihistamine dosing in children. J Allergy Clin Immunol 119:1551–1554.
   PubMed Web of Science ®Google Scholar
• Staevska, M., Popov, T.A., Kralinarkova, T., Lazarova, C., Kraeva, S., Popova, D., et al. (2009). The effectiveness of levocetirizine and desloratadine in higher than conventional doses in difficult-to-treat urticaria. Submitted for publication.
   Google Scholar
• Stark, J.G., Werner, S., Homrighausen, S., Tang, Y., Krieg, M., Derendorf, H., et al. (2006). Pharmacokinetic/pharmacodynamic modeling of total lymphocytes and selected subtypes after oral budesonide. J Pharmacokinet Pharmacodyn 33:441–459.
   PubMed Web of Science ®Google Scholar
• Stubner, P., Zieglmayer, R., Horak, F. (2004). A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit—the Vienna Challenge Chamber (VCC). Curr Med Res Opin 20:891–902.
   PubMed Web of Science ®Google Scholar
• Tai, Y.F., Piccini, P. (2004). Applications of positron emission tomography (PET) in neurology. J Neurol Neurosurg Psychiatry 75:669–676.
   PubMed Web of Science ®Google Scholar
• Tashiro, M., Duan, X., Kato, M., Miyake, M., Watanuki, S., Ishikawa, Y., et al. (2008). Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine, and diphenhydramine, measured by PET with 11C-doxepin. Br J Clin Pharmacol 65:811–821.
   PubMed Web of Science ®Google Scholar
• Tashiro, M., Mochizuki, H., Sakurada, Y., Ishii, K., Oda, K., Kimura, Y., et al. (2006). Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen. Br J Clin Pharmacol 61:16–26.
   PubMed Web of Science ®Google Scholar
• Tashiro, M., Sakurada, Y., Iwabuchi, K., Mochizuki, H., Kato, M., Aoki, M., et al. (2004). Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography. J Clin Pharmacol 44:890–900.
   PubMed Web of Science ®Google Scholar
• Tayab, Z.R., Fardon, T.C., Lee, D.K., Haggart, K., McFarlane, L.C., Lipworth, B.J., et al. (2007). Pharmacokinetic/pharmacodynamic evaluation of urinary cortisol suppression after inhalation of fluticasone propionate and mometasone furoate. Br J Clin Pharmacol 64:698–705.
   PubMed Web of Science ®Google Scholar
• Urien, S., Tillement, J.P., Ganem, B., Kuch, M.D. (1999). A pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effects of cetirizine. Int J Clin Pharmacol Ther 37:499–502.
   PubMed Web of Science ®Google Scholar
• Verster, J.C., Volkerts, E.R. (2004). Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic. Ann Allergy Asthma Immunol 92:294–303.
   PubMed Web of Science ®Google Scholar
• Wang, Z., Hamman, M.A., Huang, S.M., Lesko, L.J., Hall, S.D. (2002). Effect of St John’s Wort on the pharmacokinetics of fexofenadine. Clin Pharmacol Ther 71:414–420.
   PubMed Web of Science ®Google Scholar
• Weiland, G.A., Molinoff, P.B. (1981). Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties. Life Sci 29:313–330.
   PubMed Web of Science ®Google Scholar
• Yao, B.B., Hutchins, C.W., Carr, T.L., Cassar, S., Masters, J.N., Bennani, Y.L., et al. (2003). Molecular modeling and pharmacological analysis of species-related histamine H(3) receptor heterogeneity. Neuropharmacology 44:773–786.
   PubMed Web of Science ®Google Scholar
• Yasui-Furukori, N., Uno, T., Sugawara, K., Tateishi, T. (2005). Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics. Clin Pharmacol Ther 77:17–23.
   PubMed Web of Science ®Google Scholar
• Zuberbier, T., Bindslev-Jensen, C., Canonica, W., Grattan, C.E., Greaves, M.W., Henz, B.M., et al. (2006). EAACI/GA2LEN/EDF Guideline: definition, classification, and diagnosis of urticaria. Allergy 61:316–320.
   PubMed Web of Science ®Google Scholar
• Zweiman, B., O’Byrne, P.M., Persson, C.G.A., Church, M.K. (2006). Cellular and mediator mechanisms of the early-phase response. In: Holgate, S.T., Church, M.K., Lichtenstein, L.M. (Eds.), Allergy (pp 375–387 ). London: Mosby.
   Google Scholar